Skip to main content
. 2021 Nov 27;19(12):677. doi: 10.3390/md19120677

Table 1.

NMR data of rugukadiol A (1) in CD3OD a,b.

Position δC, Type δH, m (J in Hz) Position δC, Type δH, m (J in Hz)
1 42.7, CH 2.53, m 11 13.4, CH3 0.92, d (7.0)
2 82.2, CH 4.66, ddd (8.6, 8.0, 7.5) 12 39.8, CH2 1.93, dd (12.1, 2.0)
1.49, ddd (12.1, 5.8, 1.9)
3 43.6, CH2 2.91, dd (14.5, 7.5)
1.57, dd (14.5, 8.0)
13 138.3, C
4 82.1, C 14 22.4, CH3 1.70, d (1.2)
5 76.3, CH 5.23, ddd (4.0, 1.9, 1.9) 15 127.2, CH 5.18, br t (7.4)
6 30.6, CH2 2.37, ddd (14.8, 13.4, 4.0)
1.58, m
16 27.7, CH2 2.68, m
7 40.1, CH 2.88, dd (13.4, 4.8) 17 124.2, CH 5.06, br t (7.2)
8 38.3, CH 1.97, br d (5.5) 18 132.0, C
9 53.1, CH 2.41, br d (8.5) 19 25.9, CH3 1.67, d (1.1)
10 89.3, C 20 17.9, CH3 1.64, br s
CH3COO (2) 172.9, C
CH3COO (2) 21.0, CH3 2.03, s
CH3COO (5) 172.8, C
CH3COO (5) 21.5, CH3 2.09, s

a 1H at 500 MHz, 13C at 125 MHz; b assignments aided by COSY, HSQC, HMBC, and NOESY experiments.